Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects

Clinical trial NCT00938366 · COMPLETED

Trial details

NCT number: NCT00938366
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2008-01-01
Primary completion: 2009-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.